Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,714 | 53,820 | 71,436 | 81,479 | 23,584 |
| Receivables | 2,085 | 3,221 | 3,361 | 979 | 1,189 |
| Other current assets | 10,482 | 9,471 | 11,846 | 12,069 | 11,895 |
| TOTAL | $45,282 | $66,512 | $86,643 | $94,527 | $36,668 |
| Non-Current Assets | |||||
| PPE Net | 5,521 | 17,918 | 17,359 | 17,005 | 16,778 |
| Investments And Advances | 464 | 439 | 332 | 324 | 321 |
| Intangibles | 15 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 8 | 10 | 9 | 1 |
| TOTAL | $6,000 | $18,365 | $17,700 | $17,338 | $17,100 |
| Total Assets | $51,282 | $72,953 | $93,346 | $101,625 | $44,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,213 | 21,681 | 20,611 | 19,738 | 18,223 |
| Other current liabilities | 58,289 | 42,095 | 40,251 | 34,241 | 36,138 |
| TOTAL | $71,560 | $63,774 | $60,862 | $53,978 | $54,361 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 57 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 57,996 | 80,279 | 55,934 | 49,641 | 48,344 |
| TOTAL | $57,996 | $80,279 | $55,934 | $49,641 | $48,344 |
| Total Liabilities | $129,556 | $144,051 | $116,797 | $103,619 | $102,705 |
| Shareholders' Equity | |||||
| Common Shares | 1,643 | 1,540 | 1,532 | 1,530 | 1,153 |
| Retained earnings | -6,111 | -73,726 | -362,323 | -42,967 | -339,177 |
| Other shareholders' equity | -428,832 | -337,331 | 546 | -299,039 | 527 |
| TOTAL | $-78,274 | $-71,098 | $-23,452 | $-1,995 | $-58,645 |
| Total Liabilities And Equity | $51,282 | $72,953 | $93,346 | $101,624 | $44,060 |